Altamira Therapeutics Ltd. (CYTO)
Market Open
10 Feb, 21:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 30
0
0%
$
1.13M Market Cap
- P/E Ratio
- Div Yield
724,295 Volume
- Eps
$ 0.3
Previous Close Want to track CYTO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Auris (CYTO) Is a Great 'Buy the Bottom' Stock Now
Auris (CYTO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Zacks | 1 year ago
Altamira Therapeutics Ltd. (CYTO) Q2 2024 Earnings Call Transcript
Altamira Therapeutics Ltd. (NASDAQ:CYTO ) Q2 2024 Results Conference Call September 24, 2024 8:30 AM ET Company Participants Thomas Meyer - Founder, Chairman & Chief Executive Officer Covadonga Paneda - Chief Operating Officer Conference Call Participants Hunter Diamond - Diamond Equity Operator Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call.
Seekingalpha | 1 year ago
